Sirolimus

LIM domain binding 3 ; Homo sapiens







59 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30938569 Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty. 2020 Jan 1
2 27558119 Nine-year follow-up of progressive peri-stent contrast staining after Cypher sirolimus-eluting stent implantation: a case report. 2017 Jul 2
3 28846543 Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents. 2017 Dec 20 1
4 26875959 Calcification around the Struts of a Sirolimus-eluting Stent Approximately 16 Months after Implantation in an Autopsy Case. 2016 1
5 23996918 Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial. 2014 May 1 1
6 24717233 Atherosclerotic change at one year after implantation of Endeavor zotarolimus-eluting stent vs. everolimus-eluting stent. 2014 1
7 23182942 Long-term efficacy of sirolimus-eluting stent for small vessel disease--subanalysis of Cypher Stent Japan Post-Marketing Surveillance Registry. 2013 Jan 1
8 22424016 Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. 2012 Mar 1
9 22533814 Pore networks and polymer rearrangement on a drug-eluting stent as revealed by correlated confocal Raman and atomic force microscopy. 2012 May 29 1
10 21251624 Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). 2011 Jan 2
11 21394029 Five-year clinical follow-up after sirolimus-eluting stent implantation for the treatment of coronary in-stent restenosis. 2011 May 2
12 20405134 Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points. 2010 Oct 1
13 20542782 Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. 2010 Apr 1
14 22187903 [Long-term follow-up use of "cypher" sirolimus-eluting stents in patients with coronary heart disease after coronary artery bypass grafting with occlusive lesions of the coronary artery]. 2010 Aug-Dec 1
15 19166687 Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial. 2009 Feb 1 2
16 19406341 Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). 2009 May 5 1
17 19564562 Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. 2009 Jul 14 1
18 19670915 Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment. 2009 1
19 19858414 Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry. 2009 Nov 10 2
20 17434617 Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry. 2008 Apr 25 2
21 17876804 Quantitative spatial distribution of sirolimus and polymers in drug-eluting stents using confocal Raman microscopy. 2008 Apr 1
22 18064507 Sirolimus eluting stent (Cypher) in patients with diabetes mellitus: results from the German Cypher Stent Registry. 2008 Feb 2
23 18300741 Higher incidence and serum levels of minor cardiac biomarker elevation in sirolimus-eluting stent (Cypher) than bare metal stent implantations. 2008 Mar 2
24 18306306 An investigation of adhesion in drug-eluting stent layers. 2008 Oct 1
25 18317669 Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry. 2008 Jul 1
26 18510342 Multivariate analysis applied to the study of spatial distributions found in drug-eluting stent coatings by confocal Raman microscopy. 2008 Jul 1 1
27 18798379 Long-term efficacy and safety of sirolimus-eluting vs bare-metal stents. 2008 Sep 1
28 17195205 Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries. 2007 Feb 1 1
29 17379975 Angiographic and clinical outcome following sirolimus-eluting stent (Cypher) implantation. A single center experience. 2007 Jan 1
30 17631219 Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. 2007 Jul 17 1
31 17652906 Predictors of target lesion revascularization and documented stent thrombosis beyond 30 days after sirolimus-eluting stent implantation: retrospective analysis in consecutive 1,070 angiographic follow-up lesions. 2007 Aug 1
32 17669686 Long-term clinical follow-up of sirolimus-eluting (CYPHER) coronary stents in the treatment of instent restenosis in an unselected population. 2007 Dec 2
33 17700411 Treatment of restenosis after bare-metal and drug-eluting stenting of an aorto-ostial lesion: challenges associated with excessive stent overhang. 2007 Sep 1
34 17906340 Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study. 2007 Oct 1
35 17969375 Drug eluting stents: focus on Cypher sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions. 2007 1
36 19153436 Pathology of drug-eluting stents: implications for coronary intervention. 2007 Mar-Apr 1
37 16273582 Eosinophilic tissue response several weeks after sirolimus-eluting Cypher stent implantation within a bare metal stent in a coronary saphenous vein graft. 2006 Jan 1
38 16386683 Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. 2006 Jan 3 1
39 16461045 Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents. 2006 Feb 15 2
40 16474302 [In-hospital and remote results of the use of sirolimus coated coronary stent CYPHER]. 2006 1
41 16487832 Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. 2006 Feb 21 1
42 16598544 [Stent therapy with diabetic patients who have coronary artery disease]. 2006 Jan 1
43 16715886 [Drug-eluting stents restenosis 2 months after the procedure and necessitating semi-emergency off-pump coronary artery bypass]. 2006 May 1
44 16864948 Documented subacute stent thrombosis within thirty days after stenting with sirolimus-eluting stent (Cypher) for acute myocardial infarction: a Japanese single center retrospective non-randomized study. 2006 Aug 2
45 16881976 Sirolimus-eluting stent in chronic total occlusion: the SICTO study. 2006 Aug 3
46 17106136 Effectiveness of a sirolimus-eluting stent (Cypher) for diffuse in-stent restenosis inside a bare metal stent. 2006 Sep 2
47 17107279 Cypher versus Taxus: the stent war. 2006 Dec 1
48 17249257 Very late stent thrombosis after implantation of drug eluting stent. 2006 Nov 1
49 17407958 [Use of "Cypher" sirolimus-eluting stents in coronary heart disease patients with different types of coronary arterial lesions]. 2006 May-Jun 1
50 15737962 Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. 2005 Jul 1